|
Name |
(-)-beta-Sesquiphellandrene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(3R)-3-[(2S)-6-methylhept-5-en-2-yl]-6-methylidenecyclohexene
|
|
SMILES |
C[C@@H](CCC=C(C)C)[C@H]1CCC(=C)C=C1
|
|
InChI |
InChI=1S/C15H24/c1-12(2)6-5-7-14(4)15-10-8-13(3)9-11-15/h6,8,10,14-15H,3,5,7,9,11H2,1-2,4H3/t14-,15+/m0/s1
|
|
InChIKey |
PHWISBHSBNDZDX-LSDHHAIUSA-N
|
|
Synonyms |
beta-Sesquiphellandrene; (-)-beta-Sesquiphellandrene; 20307-83-9; (-)-(6R,7S)-sesquiphellandrene; (3R)-3-[(2S)-6-methylhept-5-en-2-yl]-6-methylidenecyclohexene; (-)-.beta.-Sesquiphellandrene; (R)-3-Methylene-6-((S)-6-methylhept-5-en-2-yl)cyclohex-1-ene; (R)-3-methylene-6-[(S)-6-methylhept-5-en-2-yl]-cyclohex-1-ene; .beta.-Sesquiphellandrene; T636HYS7CY; Cyclohexene, 3-[(1S)-1,5-dimethyl-4-hexen-1-yl]-6-methylene-, (3R)-; CYCLOHEXENE, 3-((1S)-1,5-DIMETHYL-4-HEXEN-1-YL)-6-METHYLENE-, (3R)-; CHEBI:64361; SESQUIPHELLANDRENE, (-)-.BETA.-; Q27133237; (6S)-2-Methyl-6-[(1R)-4-methylenecyclohex-2-enyl]hept-2-ene; (3R)-3-[(2S)-6-methylhept-5-en-2-yl]-6-methylidenecyclohex-1-ene; 2-HEPTENE, 2-METHYL-6-(4-METHYLENE-2-CYCLOHEXEN-1-YL)-, (1'R,6S)-(-)-; 1353-10-2
|
|
CAS | 20307-83-9 | |
PubChem CID | 12315492 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 5.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.547 |
Caco-2 Permeability: | -4.535 | MDCK Permeability: | 0.00001690 |
Pgp-inhibitor: | 0.588 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.27 | Plasma Protein Binding (PPB): | 97.46% |
Volume Distribution (VD): | 5.406 | Fu: | 2.80% |
CYP1A2-inhibitor: | 0.879 | CYP1A2-substrate: | 0.355 |
CYP2C19-inhibitor: | 0.377 | CYP2C19-substrate: | 0.859 |
CYP2C9-inhibitor: | 0.354 | CYP2C9-substrate: | 0.382 |
CYP2D6-inhibitor: | 0.031 | CYP2D6-substrate: | 0.308 |
CYP3A4-inhibitor: | 0.534 | CYP3A4-substrate: | 0.454 |
Clearance (CL): | 13.401 | Half-life (T1/2): | 0.219 |
hERG Blockers: | 0.091 | Human Hepatotoxicity (H-HT): | 0.817 |
Drug-inuced Liver Injury (DILI): | 0.388 | AMES Toxicity: | 0.022 |
Rat Oral Acute Toxicity: | 0.027 | Maximum Recommended Daily Dose: | 0.457 |
Skin Sensitization: | 0.967 | Carcinogencity: | 0.755 |
Eye Corrosion: | 0.402 | Eye Irritation: | 0.959 |
Respiratory Toxicity: | 0.9 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000383 | 0.511 | D0M1PQ | 0.367 | ||||
ENC002218 | 0.414 | D0W6DG | 0.207 | ||||
ENC002844 | 0.390 | D03VFL | 0.202 | ||||
ENC001981 | 0.367 | D0O1UZ | 0.182 | ||||
ENC000230 | 0.346 | D0K5WS | 0.178 | ||||
ENC000311 | 0.346 | D02VPX | 0.175 | ||||
ENC000796 | 0.344 | D08SVH | 0.171 | ||||
ENC001455 | 0.333 | D0T2PL | 0.171 | ||||
ENC000804 | 0.333 | D02ZGI | 0.171 | ||||
ENC003092 | 0.328 | D0P4MT | 0.171 |